AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28496141 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position ventilation endotracheal tube (PPT)
Number of subjects: 80
Study 28496141 — intervention group
Group type: COMPARATOR
Intervention: Traditional routine endotracheal tube (TT)
Number of subjects: 80
Study 26063180 — intervention group
Group type: EXPERIMENTAL
Intervention: snus trial
Number of subjects: 258
Study 26063180 — intervention group
Group type: EXPERIMENTAL
Intervention: dissolvable tobacco trial
Number of subjects: 258
Study 26063180 — intervention group
Group type: EXPERIMENTAL
Intervention: medicinal nicotine trial
Number of subjects: 258
Study 26063180 — intervention group
Group type: COMPARATOR
Intervention: control group (no trial)
Number of subjects: 258
Study 24035673 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet-delivered cognitive behaviour therapy (ICBT)
Number of subjects: 69
Study 24035673 — intervention group
Group type: COMPARATOR
Intervention: Group-based cognitive behaviour therapy (CBT)
Number of subjects: 69
Study 22187792 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 ml (75 microg) plus 5 ml 0.25% bupivacaine
Number of subjects: 60
Study 22187792 — intervention group
Group type: COMPARATOR
Intervention: 5 ml 0.25% bupivacaine plus 0.5 ml of normal saline (NS)
Number of subjects: 60
Study 19001516 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid (20%, 40 ml/h) plus heparin (250 units/h)
Number of subjects: 24
Study 19001516 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (40 ml/h) plus heparin (250 units/h)
Number of subjects: 24
Study 16775568 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tracheostomy
Number of subjects: 200
Study 16775568 — intervention group
Group type: COMPARATOR
Intervention: Surgical tracheostomy
Number of subjects: 200
Study 15381869 — intervention group
Group type: EXPERIMENTAL
Intervention: Technegas ventilation scintigraphy (TcGS) with thyroid visualization
Number of subjects: 114
Study 15381869 — intervention group
Group type: EXPERIMENTAL
Intervention: Technegas ventilation scintigraphy (TcGS) in a prospective group
Number of subjects: 114
Study 11450717 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg retina flowmeter (HRF) examination in patients with ischaemic macular branch retinal vein occlusion
Number of subjects: 10
Study 11450717 — intervention group
Group type: COMPARATOR
Intervention: Heidelberg retina flowmeter (HRF) examination in control group (healthy volunteers)
Number of subjects: 10
Study 9869250 — intervention group
Group type: EXPERIMENTAL
Intervention: Information pack containing various Stroke Association publications
Number of subjects: 71
Study 9869250 — intervention group
Group type: COMPARATOR
Intervention: Control group (received nothing)
Number of subjects: 71
Study 8027497 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate eye drops (Opticrom 2%) used regularly (four times daily)
Number of subjects: 62
Study 8027497 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate eye drops (Opticrom 2%) used as needed (up to four times daily)
Number of subjects: 62
Study 2510274 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 1918
Study 2510274 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (Control)
Number of subjects: 1918
Study 2510274 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory variables (Rioprostil)
Number of subjects: 1918
Study 952693 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% etiodocaine HCl 20 ml with adrenaline 5 mug/ml
Number of subjects: 5
Study 952693 — intervention group
Group type: COMPARATOR
Intervention: 0.75% bupivacaine HCl 20 ml with adrenaline 5 mug/ml
Number of subjects: 5
Study 31919049 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 190
Study 31919049 — intervention group
Group type: COMPARATOR
Intervention: No adenotonsillectomy (NoAT)
Number of subjects: 190
Study 30421869 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training (2 sessions/week for 12 weeks)
Number of subjects: 15
Study 30421869 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 matched MeS patients who did not exercise)
Number of subjects: 15
Study 29041954 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training (CCT) and Supported Employment (SE)
Number of subjects: 0
Study 29041954 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25853602 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cross‐cultural communication module (n=60)
Number of subjects: 119
Study 25853602 — intervention group
Group type: COMPARATOR
Intervention: Standard curriculum only (Control group, n=59)
Number of subjects: 119
Study 23567927 — intervention group
Group type: EXPERIMENTAL
Intervention: Medifast 5 & 1 Plan (MD)
Number of subjects: 120
Study 23567927 — intervention group
Group type: COMPARATOR
Intervention: Reduced-energy, food-based diet (FB)
Number of subjects: 120
Study 22094092 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous respiration
Number of subjects: 76
Study 22094092 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 76
Study 19827465 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg/kg body mass
Number of subjects: 12
Study 19827465 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 17378844 — intervention group
Group type: EXPERIMENTAL
Intervention: PKVP
Number of subjects: 40
Study 17378844 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 40
Study 15479310 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 47
Study 12815781 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 102
Study 12815781 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 102
Study 9266456 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg BSH/kg body weight administered 2.5‐16 hrs prior to tumor removal
Number of subjects: 11
Study 9266456 — intervention group
Group type: EXPERIMENTAL
Intervention: BNCT using thermal neutrons
Number of subjects: 11
Study 8300831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (0.1 mM)
Number of subjects: 31
Study 8300831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (higher concentrations)
Number of subjects: 31
Study 8300831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (2 mM)
Number of subjects: 31
Study 8300831 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 31
Study 3546611 — intervention group
Group type: EXPERIMENTAL
Intervention: DES-CEF (cyclophosphamide, 600 mg/m2; DES, 1 mg orally on days 5, 6, and 7; epidoxorubicin, 60 mg/m2; 5-fluorouracil, 600 mg/m2)
Number of subjects: 117
Study 3546611 — intervention group
Group type: COMPARATOR
Intervention: CEF (cyclophosphamide, 600 mg/m2; epidoxorubicin, 60 mg/m2; 5-fluorouracil, 600 mg/m2)
Number of subjects: 117
Study 31222615 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief coping-focused psychotherapy (Brief-PsT)
Number of subjects: 284
Study 31222615 — intervention group
Group type: COMPARATOR
Intervention: Short-term psychotherapy (Short-PsT)
Number of subjects: 284
Study 28681986 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg)
Number of subjects: 310
Study 28681986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 30284429 — intervention group
Group type: COMPARATOR
Intervention: Medication (conservative therapy)
Number of subjects: 55
Study 30284429 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneling liver shunt operation
Number of subjects: 55
Study 25381789 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program using goal setting based on G-AP
Number of subjects: 60
Study 25381789 — intervention group
Group type: COMPARATOR
Intervention: Patient information leaflets about stroke
Number of subjects: 60
Study 22795205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (20 individual sessions)
Number of subjects: 204
Study 22795205 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (6 sessions)
Number of subjects: 204
Study 20509923 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to optimize job resources and recovery opportunities implemented in 4 intervention wards.
Number of subjects: 8
Study 20509923 — intervention group
Group type: COMPARATOR
Intervention: Comparison wards (control group) with no specified interventions.
Number of subjects: 8
Study 17574801 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly structured contingency management intervention (experimental group, n = 51)
Number of subjects: 100
Study 17574801 — intervention group
Group type: COMPARATOR
Intervention: Standard methadone treatment (control group, n = 49)
Number of subjects: 100
Study 15850918 — intervention group
Group type: EXPERIMENTAL
Intervention: 125I (144 Gy)
Number of subjects: 270
Study 15850918 — intervention group
Group type: EXPERIMENTAL
Intervention: 103Pd (125 Gy)
Number of subjects: 270
Study 15850918 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose regions (V100 >= 90%)
Number of subjects: 270
Study 15850918 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose regions (V100 < 90%)
Number of subjects: 270
Study 12825092 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg oral dose of caffeine freebase
Number of subjects: 94
Study 12825092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 10575901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pap-test screening
Number of subjects: 294
Study 8762218 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 20 mg-hydrochlorothiazide 12.5 mg
Number of subjects: 240
Study 8762218 — intervention group
Group type: COMPARATOR
Intervention: enalapril 20 mg-nifedipine SL 20 mg x 2
Number of subjects: 240
Study 1342582 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate with 2% pilocarpine hydrochloride given twice a day
Number of subjects: 360
Study 1342582 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol with 4% pilocarpine given twice a day
Number of subjects: 360
Study 3843115 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions for control over noise
Number of subjects: 150
Study 3843115 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 150
Study 3843115 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-induced stress
Number of subjects: 150
Study 31612981 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive methods (various types including contraceptive pill, withdrawal, breast-feeding)
Number of subjects: 400
Study 31612981 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, duration of marriage, and high monthly income
Number of subjects: 400
Study 29355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution-based methods (0.2 SD of baseline POEM scores)
Number of subjects: 300
Study 29355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution-based methods (0.5 SD of baseline POEM scores)
Number of subjects: 300
Study 29355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-/parent-reported anchor-based methods
Number of subjects: 300
Study 29355894 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator-reported anchor-based methods
Number of subjects: 300
Study 27925082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention-group (a) - health counseling, nutrition and physical activity
Number of subjects: 42
Study 27925082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention-group (b) - health counseling, nutrition and physical activity
Number of subjects: 42
Study 24823280 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 47
Study 24823280 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin-based OAD
Number of subjects: 47
Study 23659733 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued warfarin treatment
Number of subjects: 681
Study 23659733 — intervention group
Group type: COMPARATOR
Intervention: Bridging therapy with heparin
Number of subjects: 681
Study 20632044 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic fixation transition (DFT)
Number of subjects: 60
Study 20632044 — intervention group
Group type: COMPARATOR
Intervention: Circumferential single‐level fusion (SLF)
Number of subjects: 60
Study 20632044 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DFT and SLF)
Number of subjects: 60
Study 18444052 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention programs
Number of subjects: 0
Study 18444052 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovaas's treatment
Number of subjects: 0
Study 18444052 — intervention group
Group type: EXPERIMENTAL
Intervention: Other treatments
Number of subjects: 0
Study 18444052 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 15882879 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg per day p.o. for 1 week pre-operatively)
Number of subjects: 23
Study 15882879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 12519286 — intervention group
Group type: EXPERIMENTAL
Intervention: Care delivered by a clinical nurse specialist (CNS) in a rheumatology outpatient clinic (12 weeks)
Number of subjects: 210
Study 12519286 — intervention group
Group type: COMPARATOR
Intervention: Inpatient team care (2 weeks)
Number of subjects: 210
Study 12519286 — intervention group
Group type: COMPARATOR
Intervention: Day patient team care (3 weeks)
Number of subjects: 210
Study 12519286 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups (CNS, inpatient, day patient)
Number of subjects: 210
Study 10658883 — intervention group
Group type: EXPERIMENTAL
Intervention: JOBS workshop
Number of subjects: 1801
Study 10658883 — intervention group
Group type: COMPARATOR
Intervention: Baseline job-search motivation and sense of mastery
Number of subjects: 1801
Study 10658883 — intervention group
Group type: COMPARATOR
Intervention: Initial low levels of job-search motivation and mastery
Number of subjects: 1801
Study 9289463 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women in the III trimester of gestation
Number of subjects: 325
Study 9289463 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerperium (third day after delivery)
Number of subjects: 325
Study 9289463 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord serum of newborn infants
Number of subjects: 325
Study 1502420 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligoallergenic diet
Number of subjects: 1339
Study 1502420 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind food challenge
Number of subjects: 1339
Study 1502420 — intervention group
Group type: COMPARATOR
Intervention: Food allergy/asthma prevalence
Number of subjects: 1339
Study 1502420 — intervention group
Group type: COMPARATOR
Intervention: Food antigen positivity
Number of subjects: 1339
Study 6745850 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 115
Study 30587949 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 12
Study 30587949 — intervention group
Group type: COMPARATOR
Intervention: Strength Training (ST)
Number of subjects: 12
Study 29599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Patient-based training session
Number of subjects: 170
Study 29599421 — intervention group
Group type: COMPARATOR
Intervention: Video-recorded standard lecture
Number of subjects: 170
Study 27978842 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 0
Study 27978842 — intervention group
Group type: COMPARATOR
Intervention: Traditional management
Number of subjects: 0
Study 25267738 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) continued for an additional 6 months (group A1)
Number of subjects: 347
Study 25267738 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight heparin (LMWH) discontinued (group A2)
Number of subjects: 347
Study 25267738 — intervention group
Group type: COMPARATOR
Intervention: No LMWH (group B)
Number of subjects: 347
Study 25267738 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 347
Study 22337161 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid blockade (8 mg naloxone i.v.)
Number of subjects: 76
Study 22337161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 19194341 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone 2 mg/estradiol 1 mg (group 1; n = 15)
Number of subjects: 30
Study 19194341 — intervention group
Group type: COMPARATOR
Intervention: Norethisterone acetate 0.5 mg/estradiol 1 mg (group 2; n = 15)
Number of subjects: 30
Study 17458908 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA screening)
Number of subjects: 0
Study 17458908 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no screening)
Number of subjects: 0
Study 16014067 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose dalteparin (bolus of 40 IU/kg body weight)
Number of subjects: 10
Study 16014067 — intervention group
Group type: COMPARATOR
Intervention: No additional anticoagulation
Number of subjects: 10
Study 16014067 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose dalteparin
Number of subjects: 10
Study 16014067 — intervention group
Group type: COMPARATOR
Intervention: Standard oral anticoagulation (phenprocoumon)
Number of subjects: 10
Study 11894705 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physical therapy (3.6 hours/week)
Number of subjects: 88
Study 11894705 — intervention group
Group type: COMPARATOR
Intervention: Control group (1.9 hours/week)
Number of subjects: 88
Study 11894705 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 10618886 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) at a dose of 0.7 IU/kg per week for 12 months
Number of subjects: 20
Study 10618886 — intervention group
Group type: COMPARATOR
Intervention: Non-GH treated (control)
Number of subjects: 20
Study 7605770 — intervention group
Group type: COMPARATOR
Intervention: 12 mg hyperbaric 0.75% bupivacaine in 8.25% dextrose
Number of subjects: 28
Study 7605770 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric 0.75% bupivacaine in 8.25% dextrose
Number of subjects: 28
Study 1664824 — intervention group
Group type: EXPERIMENTAL
Intervention: Temafloxacin
Number of subjects: 3355
Study 1664824 — intervention group
Group type: COMPARATOR
Intervention: Quinolone comparators
Number of subjects: 3355
Study 1664824 — intervention group
Group type: COMPARATOR
Intervention: Non-quinolone comparators
Number of subjects: 3355
Study 1664824 — intervention group
Group type: EXPERIMENTAL
Intervention: Temafloxacin (high dose)
Number of subjects: 3355
Study 6184567 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 43
Study 6184567 — intervention group
Group type: COMPARATOR
Intervention: Diuretic therapy
Number of subjects: 43
Study 6184567 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 43
Study 31625954 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (20 U for forehead lines, 20 U for glabellar lines, with/without 24 U in crow's feet)
Number of subjects: 176
Study 31625954 — intervention group
Group type: COMPARATOR
Intervention: OnabotulinumtoxinA
Number of subjects: 176
Study 29924167 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity clinical simulation
Number of subjects: 52
Study 29924167 — intervention group
Group type: COMPARATOR
Intervention: Conventional laboratory practice class
Number of subjects: 52
Study 26517954 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 189
Study 26517954 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Therapy (RT)
Number of subjects: 189
Study 25032141 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg/kg
Number of subjects: 84
Study 25032141 — intervention group
Group type: COMPARATOR
Intervention: No sedative medication (Control)
Number of subjects: 84
Study 22146238 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg/day)
Number of subjects: 30
Study 22146238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20636634 — intervention group
Group type: EXPERIMENTAL
Intervention: Valnoctamide (600 mg/day increased to 1200 mg after four days)
Number of subjects: 32
Study 20636634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 18198637 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of propofol (Pro I)
Number of subjects: 60
Study 18198637 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Shenting (DU24) and Yintang (EX‐HN3) with needle retention
Number of subjects: 60
Study 18198637 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Shenting (DU24) and Yintang (EX‐HN3)
Number of subjects: 60
Study 18198637 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 60
Study 18198637 — intervention group
Group type: COMPARATOR
Intervention: BIS measurements
Number of subjects: 60
Study 15204824 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative plus absolute risk presentation
Number of subjects: 353
Study 15204824 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute risk only presentation
Number of subjects: 353
Study 15204824 — intervention group
Group type: COMPARATOR
Intervention: No risk presentation (control group)
Number of subjects: 353
Study 12068251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g/kg ethanol
Number of subjects: 34
Study 12068251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 g/kg ethanol
Number of subjects: 34
Study 12068251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 9871427 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine treatment after 3, 5, and 11 weeks
Number of subjects: 141
Study 9871427 — intervention group
Group type: COMPARATOR
Intervention: Placebo during run-in phase
Number of subjects: 141
Study 9871427 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine treatment after 8 weeks
Number of subjects: 141
Study 8563674 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention (n = 16)
Number of subjects: 27